TrialThe New England journal of medicine2012
Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
Ronald F van Vollenhoven et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
472 papers cite itlatest 60 shown
this paperpooled ittrialcites it